IQVIA Holdings Inc. logo IQV - IQVIA Holdings Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
1
BUY 35
HOLD 7
SELL 1
STRONG
SELL
0
| PRICE TARGET: $219.44 DETAILS
HIGH: $250.00
LOW: $185.00
MEDIAN: $215.00
CONSENSUS: $219.44
UPSIDE: 30.80%

About IQVIA Holdings Inc. (https://www.iqvia.com)

IQVIA Holdings Inc. is a premier global provider of sophisticated analytical insights, advanced technology solutions, and comprehensive clinical research services, catering to the life sciences industry across the Americas, Europe, Africa, and Asia-Pacific. The company's operations are structured into three key divisions: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides a suite of cloud-native applications, complete with implementation services, and offers real-world data solutions designed to empower life sciences and healthcare providers in generating and disseminating evidence crucial for informed decision-making and improving patient outcomes. This division also delivers strategic and operational consulting, including advanced analytics support and outsourcing of commercial processes. Furthermore, it supplies country-level performance metrics detailing pharmaceutical sales, prescribing trends, medical treatments, and promotional activities across diverse channels like retail, hospital, and mail order, with data granularity extending to regional, postal code, and individual prescriber levels. Focusing on clinical trials, the Research & Development Solutions segment offers project management, clinical monitoring, broader clinical trial support, virtual trial capabilities, and strategic planning and design services. It also manages an extensive network of laboratory services, encompassing central, genomic, bioanalytical, ADME, discovery, vaccine, and biomarker analyses. The Contract Sales & Medical Solutions segment is responsible for engaging healthcare professionals and patients, alongside providing scientific strategy and medical affairs support. IQVIA's diverse clientele includes pharmaceutical, biotechnology, medical device and diagnostic, and consumer health companies. The company maintains a strategic collaboration with HealthCore, Inc. Founded in 1982, the firm was formerly known as Quintiles IMS Holdings, Inc. before rebranding as IQVIA Holdings Inc. in November 2017. Its headquarters are located in Durham, North Carolina.

Key Executives

NAME TITLE DOB SALARY
Ari Bousbib Chief Executive Officer & Chairman 1961 $7,160,123 USD
Michael J. Fedock Executive Vice President & Chief Financial Officer 1976 $2,207,406 USD
W. Richard Staub President of Research & Development Solutions 1963 $1,829,079 USD
Alistair Grenfell President of Commercial Solutions 1974 $1,704,592 USD
Eric Sherbet Executive Vice President, General Counsel & Secretary 1964 $1,500,870 USD
Duane Sachs Senior Vice President of Corporate Development
James G. Berkshire Executive Vice President of Global Infrastructure & Operations 1974
Jeffrey A. Spaeder Chief Medical & Scientific Officer
Keriann Cherofsky Senior Vice President, Corporate Controller & Chief Accounting Officer 1985
Kerri Joseph Senior VP of Investor Relations & Treasurer

Company Peers

Peer analysis pending, check back in 1-2 minutes.